𝔖 Bobbio Scriptorium
✦   LIBER   ✦

BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia

✍ Scribed by Alexandra Ortiz Rodríguez; Marcia Llacuachaqui; Gonzalo Guevara Pardo; Robert Royer; Garrett Larson; Jeffrey N. Weitzel; Steven A. Narod

Book ID
113963500
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
620 KB
Volume
124
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BRCA1 and BRCA2 mutations among breast c
BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines
✍ Maria Lourdes De Leon Matsuda; Alexander Liede; Elaine Kwan; Cynthia A. Mapua; E 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 183 KB 👁 2 views

## Abstract Age‐adjusted incidence rates of breast cancer vary more than 10‐fold worldwide, with the highest rates reported in North America and Europe. The highest breast cancer incidence rates in Southeast Asia have been reported for the Manila Cancer Registry in the Philippines, with an age‐stan

BRCA1 and BRCA2 mutations in breast/ovar
BRCA1 and BRCA2 mutations in breast/ovarian cancer patients from central Italy
✍ L. Stuppia; P. Di Fulvio; G. Aceto; S. Pintor; S. Veschi; V. Gatta; A. Colosimo; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

We report on the screening of the entire BRCA1/BRCA2 coding sequence by SSCP, PTT, and direct sequencing in 68 Italian families with recurrent breast or ovarian cancer. For each investigated proband, the probability of being carrier of a BRCA1/BRCA2 mutation was evaluated using the BRCAPRO software.

Prevalence of founder BRCA1 and BRCA2 mu
Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in hungary
✍ Marco Van der Looij; Csilla Szabo; Istvan Besznyak; Gyorgy Liszka; Bela Csokay; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 55 KB 👁 2 views

We have investigated the impact of BRACA1 and BRACA2 mutations that were frequently identified among Hungarian high-risk breast-ovarian cancer families (Ramus et al., 1997b, AJHG), on the development of breast and ovarian cancer in the general Hungarian population. The prevalence of 3 BRCA1 mutation